Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention

Current oral antiretroviral agents provide highly effective treatment for patients infected with human immunodeficiency virus (HIV), and can be used as pre-exposure prophylaxis (PrEP) to prevent new HIV infections. Several single-tablet regimens with excellent antiviral efficacy have dramatically im...

Descripción completa

Detalles Bibliográficos
Autor principal: Kim, Yeon-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731252/
https://www.ncbi.nlm.nih.gov/pubmed/34979604
http://dx.doi.org/10.3947/ic.2021.0136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731252/
https://www.ncbi.nlm.nih.gov/pubmed/34979604
http://dx.doi.org/10.3947/ic.2021.0136

Ejemplares similares